03Jul 2023
Prognostic biomarkers for survival in mucosal melanoma

Prognostic biomarkers for survival in mucosal melanoma

Mucosal melanoma (MM) is a rare and aggressive type of melanoma. A study analyzed real-world data from 39 MM patients and found that the absence of pigmentation and the presence of NRAS/KRAS mutations are biomarkers associated with a shorter overall survival. Patients with amelanotic MM (lack of pigmentation) had significantly poorer survival, and the presence of NRAS or KRAS mutations was also linked to worse outcomes. This research reveals that the same prognostic biomarkers observed in cutaneous melanoma (CM) - lack of pigmentation and RAS mutations - are also significant prognosticators for MM.

  • #dermatology

Like

Save

Share